ClinicalTrials.govpublic full text
Memantine Hydrochloride for Treatment of Cognitive Dysfunction Due to Traumatic Brain Injury
treatment of cognitive deficits after traumatic brain injury, traumatic brain injury, closed head injury, cognition, memory, n-methyl-d-aspartate (nmda)-type receptors, nmda blocker, memantine hydrochloride, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 916262
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.